古井贡B(200596) - 2019 Q3 - 季度财报

Financial Performance - Total assets increased by 6.04% to CNY 13,265,837,811.82 compared to the end of the previous year[6]. - Net assets attributable to shareholders increased by 12.97% to CNY 8,588,195,185.21 compared to the end of the previous year[6]. - Operating revenue for the period increased by 21.31% to CNY 8,202,880,349.97 compared to the same period last year[6]. - Net profit attributable to shareholders increased by 38.69% to CNY 1,741,611,160.63 compared to the same period last year[6]. - Basic earnings per share rose by 38.96% to CNY 3.46 per share[6]. - The weighted average return on equity was 21.18%, an increase of 3.03% compared to the same period last year[6]. - The company reported a total profit of ¥2,363,912,282.92, compared to ¥1,733,404,376.97 in the previous period, marking an increase of around 36.4%[40]. - The total comprehensive income for the current period was ¥1,781,263,091.07, compared to ¥1,240,411,609.17 in the previous period, reflecting an increase of approximately 43.5%[41]. Cash Flow and Liquidity - Cash flow from operating activities decreased by 11.67% to CNY 2,241,371,504.76 compared to the same period last year[6]. - Cash and cash equivalents increased by 116.70% to ¥3,696,303,467.62 due to higher cash from sales and investment recoveries[12]. - The net cash flow from operating activities was CNY 2,241,371,504.76, down from CNY 2,537,458,914.99 in Q3 2018, indicating a decrease of about 11.7%[46]. - The net increase in cash and cash equivalents for Q3 2019 was CNY 2,356,362,486.57, significantly higher than CNY 1,266,455,062.14 in Q3 2018, representing an increase of approximately 86.1%[47]. - Cash inflow from investment activities totaled CNY 3,468,570,739.90, compared to CNY 2,046,062,023.16 in the previous year, indicating a growth of approximately 69.5%[46]. Research and Development - R&D expenses rose by 114.45% to ¥25,719,404.29, reflecting increased investment in research and development[12]. - Research and development expenses for the quarter were ¥11,055,166.62, a substantial increase from ¥3,965,869.26 in the same quarter last year, reflecting a focus on innovation[33]. - Research and development expenses increased to ¥16,286,743.25 from ¥10,431,247.70, showing a rise of approximately 56.5%[43]. Shareholder Information - The largest shareholder, Anhui Gujing Group Co., Ltd., holds 53.89% of the shares[8]. - The total number of common shareholders at the end of the reporting period is 23,360, with the top 10 shareholders holding a total of 271,404,022 shares, representing 53.89% of the total shares[70]. - The company did not engage in any repurchase transactions during the reporting period[10]. Liabilities and Equity - Total liabilities decreased to ¥4.21 billion from ¥4.48 billion, showing a reduction of about 6%[27]. - Total equity increased from ¥8,029,750,117.40 to ¥9,055,613,208.47, representing a growth of about 12.7%[90]. - The total liabilities amounted to CNY 2,239,745,186.12[59]. Other Income and Expenses - Other income surged by 280.89% to ¥44,662,596.55, primarily due to an increase in tax refunds received[12]. - The company reported a government subsidy of CNY 44,269,941.91 during the period[68]. - The company incurred financial expenses of -¥20,04 million, compared to -¥12.71 million in the previous year, indicating an increase in financial costs[105]. Investment Activities - The total amount of entrusted financial management reached ¥370,900,000, with an outstanding balance of ¥106,600,000[16]. - The company reported a derivative investment in government bond reverse repos with a total initial investment of ¥0.00 and a reportable profit of ¥0.35 million during the period[81].